Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Viking Thera
(NQ:
VKTX
)
76.97
+1.21 (+1.60%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Viking Thera
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
The 3 Most Undervalued Biotech Stocks to Buy in February 2024
February 08, 2024
With patience, some of the most undervalued biotech stocks can create massive wealth, such as these three to consider.
Via
InvestorPlace
Why Compass Minerals International Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
February 08, 2024
Shares of Compass Minerals International, Inc. (NYSE: CMP) fell sharply during Thursday’s session following downbeat results.
Via
Benzinga
Recap: Viking Therapeutics Q4 Earnings
February 07, 2024
Via
Benzinga
Earnings Scheduled For February 7, 2024
February 07, 2024
Companies Reporting Before The Bell • Madison Square Garden (NYSE:MSGE) is expected to report quarterly loss at $0.80 per share on revenue of $301.83 million.
Via
Benzinga
Earnings Preview: Viking Therapeutics
February 06, 2024
Via
Benzinga
1 Under-the-Radar Stock That Could Triple By 2030
November 04, 2023
This small-cap biotech stock is going to compete against some giants.
Via
The Motley Fool
Viking Therapeutics Charges To A Record High On An Update For Its Eli Lilly-Rivaling Obesity Drug
February 08, 2024
The company is looking to take on Eli Lilly's tirzepatide as both a shot and a pill for weight loss.
Via
Investor's Business Daily
Arm Holdings Posts Upbeat Results, Joins Hershey, CyberArk Software, Wynn Resorts And Other Big Stocks Moving Higher On Thursday
February 08, 2024
U.S. stocks traded mixed, with the Dow Jones gaining around 20 points on Thursday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
The 3 Best Biotech Stocks to Invest in for Big Gains in 2024
February 02, 2024
These pivotal biotech stocks for gains are charting the future of medicine and investment growth in 2024 offering powerful returns
Via
InvestorPlace
2 Rising Biotechs That Could Become the Next Novo Nordisk
January 29, 2024
Each of these companies has a big market in its sights.
Via
The Motley Fool
Earnings Scheduled For October 25, 2023
October 25, 2023
Companies Reporting Before The Bell • Deutsche Bank (NYSE:DB) is estimated to report quarterly earnings at $0.52 per share on revenue of $7.65 billion.
Via
Benzinga
3 Biotech Stocks to Turn $10,000 Into $1 Million: January 2024
January 22, 2024
Biotech stocks are some of the most exciting opportunities on the market. Find the right ones with catalysts, and you could make a fortune.
Via
InvestorPlace
2 Stocks That Could Soar This Year: Are They Buys?
January 22, 2024
They might perform well in 2024, but how will they do beyond that?
Via
The Motley Fool
The 3 Best Biotech Stocks to Buy in January 2024
January 09, 2024
Biotech is still one of the most exciting investments on the market, creating substantial opportunities for some of the best biotech stocks.
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
January 09, 2024
Via
Benzinga
M&A Watch: 3 Drug Maker Stocks That Could Be Acquired in 2024
January 02, 2024
Lower interest rates and the low valuation of many biotech stocks are likely to result in many drug maker stocks being acquired in 2024.
Via
InvestorPlace
Better Growth Stock: Viking Therapeutics or Iovance Biotherapeutics?
December 12, 2023
Both of these pharma stocks could be big winners. But one stock screens as a better buy from a risk standpoint.
Via
The Motley Fool
Why Viking Therapeutics Was Crushing It This Week
December 08, 2023
Nowadays, it's good to be a developer of next-generation weight loss drugs.
Via
The Motley Fool
What's Going On With Viking Therapeutics Shares Tuesday?
November 14, 2023
Viking Therapeutics Inc (NASDAQ: VKTX) shares are trading higher Tuesday after the company presented new data from its Phase 2b study
Via
Benzinga
Why Are Stocks Down Today?
October 18, 2023
Stocks are down again on Wednesday as investors continue to feel the effects of several major catalysts hitting the market.
Via
InvestorPlace
Pfizer Layoffs 2023: What to Know About the Latest PFE Job Cuts
October 18, 2023
Pfizer layoffs are a hot topic among PFE stock traders on Wednesday as they pour over the details of the job cuts amid a Covid slump.
Via
InvestorPlace
Topics
Workforce
Exposures
COVID-19
Layoff
Why Is Viking Therapeutics (VKTX) Stock Moving Today?
October 18, 2023
Viking Therapeutics stock is on the move Wednesday as investors react to results from the company's latest clinical trial!
Via
InvestorPlace
Why Talaris Therapeutics Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
October 18, 2023
Gainers Biocept, Inc. (NASDAQ: BIOC) shares surged 91.8% to $0.98 in pre-market trading after falling over 6% on Tuesday. Biocept recently filed for Chapter 7 bankruptcy in the U.S. Bankruptcy Court...
Via
Benzinga
Topics
Bankruptcy
Exposures
Financial
Legal
Jim Carmer Is 'A Seller' Of This Company Because 'Elon Musk Said That He Doesn't Like That Business'
October 11, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Abbott Laboratories (NYSE: ABT) is a "very good company and will be up to the—let’s say—up to the challenge. I think that’s fair.
Via
Benzinga
Consolidation In Viking Therapeutics Provides An Opportunity
October 01, 2023
Viking Therapeutics Inc. (VKTX) is an innovative biotechnology company developing novel therapeutics for metabolic and endocrine diseases.
Via
Talk Markets
Canopy Growth, DocGo And Other Big Stocks Moving Lower On Monday
September 18, 2023
U.S. stocks traded mostly flat on Monday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
3 Biotechs Compete for the Same $108-Billion-Dollar Market. Are They a Buy?
August 23, 2023
NASH treatments are projected to be one of the most sought-after indications in the coming years.
Via
The Motley Fool
Looking for the Next Big Biopharma Stock? These 4 Letters Are 1 Big Clue Where to Find It
August 23, 2023
NASH is a surprisingly common ailment, and the first treatments are on the way.
Via
The Motley Fool
The 7 Most Undervalued Healthcare Stocks to Buy Now: August 2023
August 16, 2023
All of these healthcare stocks to buy are underpriced and relatively stable investments over the mid-to-long term.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
August 08, 2023
Via
Benzinga
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.